Omthera announces termination of antitrust waiting period

theflyonthewall.com

Omthera announced that the FTC granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in connection with the previously announced merger agreement among Omthera Pharmaceuticals, Zeneca, and KAFA Acquisition. The termination of the waiting period satisfies one of the conditions to consummation of the proposed merger. The parties currently expect to complete the merger in the third quarter, subject to satisfaction of other closing conditions, including receipt of the approval of the Company's stockholders of the proposal to adopt the merger agreement.

View Comments (0)